Sign In
Buy DNA
$7.89
-0.110 (-1.38%)
At Close: Jun 12, 2026
50% Pop Coming For Planet Labs
02:50pm, Tuesday, 30'th Nov 2021
50% Pop Coming For Planet Labs
Ginkgo Bioworks Holdings, Inc. (DNA) CEO Jason Kelly on Q3 2021 Results - Earnings Call Transcript
06:14pm, Monday, 15'th Nov 2021
Ginkgo Bioworks Holdings, Inc. (DNA) CEO Jason Kelly on Q3 2021 Results - Earnings Call Transcript
Selecta Biosciences, Ginkgo Bioworks Join Forces To Develop Rare Disease Treatments
12:15pm, Tuesday, 26'th Oct 2021
Selecta Biosciences Inc (NASDAQ: SELB) and Ginkgo Bioworks Holdings Inc (NYSE: DNA) have collaborated to design novel and improved therapeutic potential enzymes for orphan and rare diseases. Th
Baillie Gifford Trimmed Positions In Alibaba, Tesla, Nio, Moderna In Q3, Here's What It Bought Instead
04:43am, Thursday, 21'st Oct 2021
Investment firm Baillie Gifford lowered exposure in Tesla Inc (NASDAQ:TSLA), Alibaba Group Holding (NYSE:BABA) and Nio Inc (NYSE:NIO) in the third quarter and snapped up shares in vaccine maker Modern
Why Shares of Ginkgo Bioworks Plunged Today
05:55pm, Wednesday, 20'th Oct 2021
A new project in the Lone Star state wasn't enough to convince the bears to hold on to their shares.
Ginkgo Bioworks Investor Alert
06:18pm, Monday, 18'th Oct 2021
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Ginkgo Bioworks To Contact Him Directly To Discuss Their OptionsNew York, New York--(New
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ginkgo Bioworks Holdings, Inc. - DNA
09:20pm, Friday, 15'th Oct 2021
NEW YORK, Oct. 15, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Ginkgo Bioworks Holdings, Inc. ("Ginkgo" or the "Company") (NYSE: DNA). Such investors are
Ginkgo Bioworks Shareholder Alert
06:55pm, Friday, 15'th Oct 2021
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Ginkgo Bioworks To Contact Him Directly To Discuss Their OptionsNew York, New York--(New
Los Angeles, California--(Newsfile Corp. - October 15, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of G
Ginkgo Bioworks Investor Alert
06:48pm, Thursday, 14'th Oct 2021
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Ginkgo Bioworks To Contact Him Directly To Discuss Their OptionsNew York, New York--(New
Ginkgo Bioworks Price Predictions: Why One Analyst Thinks Hard-Hit DNA Stock Can Hit $14.50
04:43pm, Thursday, 14'th Oct 2021
Today, a bullish analyst price target placed on Ginkgo Bioworks has sent DNA stock on a nice ride as investors pile into this growth play. The post Ginkgo Bioworks Price Predictions: Why One Analyst T
San Francisco, California--(Newsfile Corp. - October 13, 2021) - Hagens Berman urges Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) investors with significant losses to submit your losses now.Visit: www
Never Mind Ginkgo Bioworks' Drama -- This Synthetic Biology Stock Is Still a Buy
05:45am, Wednesday, 13'th Oct 2021
If the latest short-seller attack on Ginkgo Bioworks has you nervous about synthetic biology, consider the industry leader.
Los Angeles, California--(Newsfile Corp. - October 12, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of
DNA Stock: The Bull Call That Has Ginkgo Bioworks Bouncing Back After Last Week's “Scam” Accusation
01:55pm, Tuesday, 12'th Oct 2021
Ginkgo Bioworks (DNA) stock is doing well on Tuesday as it recovers with new coverage from an analyst with a bull stance. The post DNA Stock: The Bull Call That Has Ginkgo Bioworks Bouncing Back After
